Showing 1 - 4 results of 4 for search 'Rafael Alonso Fernández', query time: 0.03s Refine Results
  1. 1
    P840: ASSESSMENT OF CONVENTIONAL TRANSLOCATIONS AND IG REARRANGEMENTS IN THE DIAGNOSIS OF MULTIPLE MYELOMA PATIENTS USING A TARGETED CAPTURE-HYBRIDIZATION RNA SEQUENCING PANEL.

    P840: ASSESSMENT OF CONVENTIONAL TRANSLOCATIONS AND IG REARRANGEMENTS IN THE DIAGNOSIS OF MULTIPLE MYELOMA PATIENTS USING A TARGETED CAPTURE-HYBRIDIZATION RNA SEQUENCING PANEL. by Natalia Buenache Cuenda, Ricardo Sánchez, Alicia Giménez Sánchez, Laura Carneros Blanco, Rafael Alonso Fernández, José María Sánchez Pina, Inmaculada Rapado Martínez, Rosa Ayala Diaz, Joaquín Martinez-Lopez, Juan Manuel Rosa Rosa

    Published 2023-08-01
    Get full text
    Article
  2. 2
    Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study

    Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study by Rosa Ayala, Rafael Alonso Fernández, Valentín García‐Gutiérrez, Alberto Alvarez‐Larrán, Santiago Osorio, Jose M. Sánchez‐Pina, Gonzalo Carreño‐Tarragona, Noemi Álvarez, María Teresa Gómez‐Casares, Antonia Duran, Julian Gorrochategi, Juan Carlos Hernández‐Boluda, Joaquín Martínez‐López

    Published 2023-05-01
    Get full text
    Article
  3. 3
    S256: HLA-E/NKG2A CHECKPOINT DRIVES MULTIPLE MYELOMA RESISTANCE TO CAR-NK THERAPY

    S256: HLA-E/NKG2A CHECKPOINT DRIVES MULTIPLE MYELOMA RESISTANCE TO CAR-NK THERAPY by Jessica Encinas, Almudena García-Ortiz, Elena Maroto-Martín, Eva Castellano, Raquel Oliva, Rafael Alonso Fernández, Maria Teresa Cedena Romero, Alejandra Leivas, Beatriz Martín-Antonio, Guillermo Suñe, Dean A. Lee, Daniel J. Powell, Jr., Paula Río, Joaquín Martinez-Lopez, Antonio Valeri

    Published 2023-08-01
    Get full text
    Article
  4. 4
    Real-life experience with first-line treatment with daratumumab, bortezomib, melphalan, and prednisone in patients with newly diagnosed multiple myeloma ineligible for autologous stem-cell transplantation

    Real-life experience with first-line treatment with daratumumab, bortezomib, melphalan, and prednisone in patients with newly diagnosed multiple myeloma ineligible for autologous s... by Amalia Domingo-González, Rafael Alonso Fernández, Ana Jiménez, Teresa De Soto Álvarez, Ana Lerma-Verdejo, Virginia Pradillo, Gonzalo Benzo Callejo, Jose Sánchez-Pina, Elena Landete, Alberto Velasco-Valdazo, Marina Menéndez-Cuevas, Mónica María López Riñón, Andrés Ramírez-López, María-Jesús Blanchard, Elham Askari

    Published 2024-09-01
    Get full text
    Article

Search Tools: